← Back to Search

Behavioral Intervention

SURGE Support Program for Cancer Trial Enrollment

N/A

Recruiting

Led By Nadine J McCleary, MD MPH

Research Sponsored by Nadine McCleary, MD, MPH

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Gastrointestinal, hematologic, or thoracic cancer

Adult (age 18 years or older)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 90 days of enrollment

Awards & highlights

Study Summary

This trial will help researchers learn more about how best to support patients in their decision to undergo genomic testing as part of a clinical trial.

Who is the study for?

The SURGE trial is for adults over 18 with advanced gastrointestinal, blood, or lung cancer. It's focused on helping underrepresented groups like Black, Latinx, American Indian, Pacific Islander individuals, those with limited English proficiency in Spanish, older adults (70+), and people from low-income areas or facing social challenges.Check my eligibility

What is being tested?

SURGE tests a support system to help these patients join genomic-based cancer trials. The intervention includes a personal guide (navigator), text message surveys, and an educational video to overcome barriers to precision therapy access.See study design

What are the potential side effects?

Since SURGE is not testing a drug but an intervention program aimed at improving trial enrollment processes through education and navigation services, there are no direct medical side effects associated with typical clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer is in the stomach, blood, or chest area.

Select...

I am 18 years old or older.

Select...

I have an advanced cancer that needs treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 90 days of enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 90 days of enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days of enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Genomic testing uptake

Secondary outcome measures

Acceptability of questionnaire modality

Patient interaction with the intervention

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Arm C (informational video and patient navigation)Experimental Treatment1 Intervention

Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to the SURGE intervention where they will receive: Informational Video and Patient Navigation

Group II: Arm B (informational video)Experimental Treatment1 Intervention

Group III: Arm A (standard of care)Active Control1 Intervention

Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to Standard of Care (SOC) and receive: Standard of Care

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Nadine McCleary, MD, MPHLead Sponsor

Bristol-Myers SquibbIndustry Sponsor

2,641 Previous Clinical Trials

4,129,854 Total Patients Enrolled

Nadine McCleary MD, MPHLead Sponsor

Media Library

SURGE (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05375643 — N/A

Gastrointestinal Cancer Research Study Groups: Arm B (informational video), Arm A (standard of care), Arm C (informational video and patient navigation)

Gastrointestinal Cancer Clinical Trial 2023: SURGE Highlights & Side Effects. Trial Name: NCT05375643 — N/A

SURGE (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05375643 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the main goals of this clinical research endeavor?

"According to Bristol-Myers Squibb, the primary metric for assessment will be PROFILE genomic testing completion rates over a 3 year time frame. Additionally, this study is observing secondary objectives which include determining consent rate of patients with insufficient tissue samples and no archival specimens available as well as exploring correlations between patient demographics and disease characteristics with clinical trial awareness/readiness."

Answered by AI

Are there any available openings for prospective participants in this clinical trial?

"According to clinicaltrials.gov, this medical trial is not presently recruiting patients - the original posting was on November 1st 2022 and it was last updated on May 11th 2022. Although no longer seeking participants right now, there are a great deal of other research studies that are currently open for enrolment (1882)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Nadine McCleary, MD, MPH 2023. "SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05375643.